CTIS.eu › Cities › France › Saint-Cloud
Saint-Cloud
France
137 total trials
63 recruiting
2024-514904-14-00
4
2014-10-08
Patients with metastatic or unresectable locally advanced malignancies
2024-511096-15-00
5
2014-08-01
Breast Cancer
2024-516198-61-00
5
2013-06-05
Patients with high risk of relapse, ER+ and HER2- primary non-metastat
2024-516996-34-00
5
2012-04-12
oestrogen-receptor (ER)-positive HER2-negative breast carcinoma
2023-503298-39-00
5
2024-06-13
Metastatic Non-Small Cell Lung Cancer (mNSCLC)
2023-505431-12-00
1
2025-01-20
Patients with pretreated, metastatic or locally advanced cancer for th
2024-517400-11-00
6
2024-10-24
Patients with metastatic breast cancer initially presenting with overe
2022-501507-27-00
4
2024-04-17
Advanced or metastatic triple-negative breast cancer
2022-502672-23-00
3
2023-10-18
Richter's Syndrome
2022-502360-21-00
4
2023-10-12
GATA3-mutant, ER-positive, HER2-negative advanced or metastatic breast
2023-503846-30-00
9
2023-10-10
Breast Cancer
2022-502196-31-00
10
2023-08-21
Advanced or Recurrent Endometrial Cancer
2024-516111-25-00
5
2020-11-09
Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Per
2024-512050-13-00
5
2020-09-22
HER2-positive advanced breast cancer
2024-514586-20-01
5
2018-05-02
Non small cell lung cancer
2023-506487-13-00
5
Hormone receptor-positive, her2-negative advanced/metastatic breast ca
2024-516724-33-00
9
Advanced/metastatic gynecological cancer overexpressing FGFR2b
Showing 121–137 of 137 trials